A number of countries now include meningococcal vaccines in their routine immunization
programs. This review focuses on different approaches to including meningococcal vaccines …

The Global Meningococcal Initiative (GMI) is composed of an international group of
scientists, clinicians and public health officials with expertise in meningococcal immunology …

As reviewed in this paper, meningococcal disease epidemiology varies substantially by
geographic area and time. The disease can occur as sporadic cases, outbreaks, and large …

Meningococcal disease is characterized by a marked variation in incidence and serogroup
distribution by region and over time. In several European countries, Canada and Australia …

Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can
also cause sepsis, pneumonia, and other manifestations. In countries with high endemic …

Meningococcal disease continues to be a life threatening infection with high morbidity and
mortality even in appropriately treated patients. Meningococcal vaccination plays a major …

Neisseria meningitidis, a gram-negative diplococcal bacterium, is a common asymptomatic
nasopharyngeal colonizer that may infrequently lead to invasive disease in the form of …

The epidemiology of invasive meningococcal disease continues to change rapidly, even in
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …

The introduction and rollout of a meningococcal serogroup A conjugate vaccine,
MenAfriVac, in the African meningitis belt has eliminated serogroup A meningococcal …

Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide
and is associated with high case fatality rates and serious life-long complications among …